ADVANCE infectious diseases pharmacy and LEAD antimicrobial stewardship in order
to OPTIMIZE the care of patients

  • Home
  • Past Presidents' Reflections

Past Presidents' Reflections

The 30 past presidents of SIDP share milestones from their terms in office.

1991–1992

Randall Prince, PharmD, FCP, FCCP, FIDSA, FIDP 

  • SIDP article of incorporation signed on May 22, 1991

1992–1993

Michael Dudley, PharmD 
(@MikeMndudley)

  • The first SIDP meeting held during the ICAAC meeting in New Orleans on the patio of the Pharmacy Museum
  • Meeting included the Society's first sponsored Fellow's presentation

1993–1994

John Bosso, PharmD, FIDSA, FCCP, FIDP 
(@BossoJr)

  • Society is incorporated as a 501©3 in Texas, standing committees initiated
  • First standing committees formed

1994–1995

Ron Polk, PharmD, FIDSA, FSHEA  

  • Grant Funding secured from Pfizer for first SIDP research program
  • Industry began to see ID pharmacists as persons of influence

1995–1996

John Rotschafer, PharmD, FCCP

1996–1997

Steven Barriere, PharmD, FIDSA, FCCP, FIDP

1997–1998

Joseph Bertino, PharmD, FCP, FCCP  

  • At a time when the role of the ID pharmacist was often questioned, we advocated for the ability of ID pharmacists to make drug recommendations in a series of letters in CID. We then continued conversations with IDSA leadership in a face-to-face meeting that led to better cooperation and understanding from both sides
  • SIDP along with ACCP and ASHP responds to statement from IDSA on the role of pharmacists in infectious disease

1998–1999

James Garrelts, PharmD, FASHP  

  • SIDP invited to participate in a national summit with several other societies to develop national guidelines
  • The great camaraderie within the ID pharmacist community has resulted in the growth and success of our organization


1999–2000

Robert Stevens, PharmD, FCCP   

  • ID Pharmacy Residency Awards program expanded
  • SIDP members recommended to guideline panels, FDA Anti-Infective and Anti-Viral Drug Advisory Committees and the CDC Interagency Task Force on Antimicrobial Resistance

2000–2001

Peggy Carver, PharmD, FCCP, FIDP    

  • SIDP and ICAAC are postponed due to the events of September 11, 2001

2001–2002

Charles Ballow, PharmD, FCCP

2002–2003

Michael Rybak, PharmD, MPH, PhD, FCCP, FIDSA, FIDP 
(@IDpharmresearch)

  • Expanding our visibility by collaborating with other professional societies and co-sponsoring 10 educational/research programs with IDSA_ICAAC, SHEA, ACCP and MAD-ID
  • SIDP was represented in two therapeutic guideline initiatives
  • SIDP was invited to take part in an antimicrobial resistance task force in Washington, DC hosted by Richard Wenzel, MD and Ron Polk, Pharm.D. along with representatives from IDSA, CDC, SIS, ACCP, SHEA and others
  • SIDP co-sponsored a press conference at the New York Academy of Sciences in New York City on antimicrobial resistance which resulted in over 30 citations for SIDP’s active role in journals, newspapers and medical websites
  • Established a formal relationship with the journal Pharmacotherapy to include a new ID therapeutic section called “Insights from SIDP” where SIDP member authored reviews and research papers could be published under this banner
  • Development of a new interactive SIDP website that included SIDP events, news, member search functions, committee reports, the society’s newsletter and an interactive listserver
  • Established the SIDP/Pfizer Fellowship Award Program

2003–2004

Douglas Fish, PharmD, FCCM, FCCP, BCCCP, BCPS (AQ-ID), FIDP    

  • SIDP Passed the 350-member mark
  • SIDP played a key role in developing qualifications for the brand-new but very important Added Qualifications in Infectious Diseases (AQ-ID) designation by BPS
  • HIV section created
  • First year for online membership applications/renewals and electronic voting for elections

2004–2005

Steven Ebert, PharmD, FCCP, FIDSA, BCIDP     

  • Emphasis shift from industry-sponsored events to collaboration with public health organizations
  • Greater delegation to committees and member-driven activities and less reliance on Board of Directors
  • Increased focus on/support of the beneficial impacts of pharmacist-driven antimicrobial stewardship
  • First presence at IDSA Annual Meeting

2005–2006

Thomas Hardin, PharmD, MBA, FCCP

2006–2007

Michael Klepser, PharmD, FCCP, FIDP 
(@MKlepser)

  • Discovered CLIA-waived point-of-care diagnostics
  • Started to engage in outpatient antimicrobial stewardship

2007–2008

Richard Drew, PharmD, MS, FCCP, FIDP

  • Introduction of monthly emails to communicate to the membership
  • Increased support for Research Awards
  • Antimicrobial Stewardship Certificate Program creation began, thanks to David Burgess helping kickstart the program

2008–2009

Diane Cappelletty, PharmD 

  • Establishment of the Antimicrobial Stewardship Certificate Program with online self-study modules for CE developed

2009–2010

David Burgess, PharmD, FCCP, FIDP 
(@DS_Burgess)

2010–2011

Paul Gubbins, PharmD, FCCP, FIDP 
(@gubbinspaulo)

  • SIDP’s 20th Anniversary
  • SIDP Antimicrobial Stewardship Certificate Program launched
  • Partnership with ProCE began
  • Increased advocacy on national public health and Infectious Diseases issues

2011–2012

Elizabeth Hermsen, PharmD, MBA, BCPS (AQ-ID), FIDP, FIDSA 
(@ehermsenUSA)

  • SIDP is a great and immediate “Pharmily”
  • Strategic plan revised
  • Gita Patel Best Practice Award created to honor Gita Patel
  • First SIDP event during ID Week occurred as evening reception with presentation on NTAP
  • GAIN Act was passed with SIDP input and language included

2012–2013

Erika Ernst, PharmD, BCIDP, FCCP
(@ErnstErika)

  • CE offered at Annual meeting
  • Continued development of Antimicrobial Stewardship Certificate Program
  • Research and Training Grants

2013–2014

Joseph Kuti, PharmD, FIDP

  • Twitter handle @SIDPharm started allowing SIDP to educate and promote ID pharmacists internationally
  • SIDP extended a free invitation to leadership from APhA, ASHP, IDSA, and SHEA to attend our annual meeting and social event to learn about our Society
  • SIDP joined S-FAR, the Stakeholder Forum on Antimicrobial Resistance, further introducing the world to the voice of ID Pharmacists

2014–2015

David Bearden, PharmD, FIDP
(@DTBearden)

  • 2015 invitation to the White House Forum on Antibiotic Stewardship
  • Expanding national advocacy presence
  • Expansion of the Antimicrobial Stewardship Certificate Program

2015–2016

Jason Gallagher, PharmD, FCCP, FIDSA, BCPS, FIDP
(@JGPharmD)

  • Creation of SIDPEC
  • Creation of Long-Term Care (LTC) Antimicrobial Stewardship Certificate Program
  • SIDP logo modernized 

2016–2017

Melinda Neuhauser, PharmD, MPH, FCCP, FASHP, FIDP

  • First SIDP Annual Meeting in conjunction with IDWeekTM with the inaugural induction of Fellowship of SIDP (FIDP)
  • Initiated strategic planning to serve as the foundation for SIDP’s future internal and external growth to enhance our organizational structure, efficiency, communication, and impact
  • Completed comprehensive financial audit with plan to incorporate into organization structure
  • Competitive re-bid of management company contract that led to switching from EAMI to Affinity Strategies

2017–2018

Elizabeth Dodds Ashley, PharmD, MHS, FCCP, FIDP, BCPS
(@The_Real_LDA)

  • Launched the year with updated strategic plan and the shared vision of safe and effective antimicrobials for now and the future
  • SIDP joined as a supporter of Global AMR challenge solidifying the organization's role on the international stage
  • Joined with our new management company (Affinity Strategies)
  • Selected as BCIDP recertification credit provider

2018–2019

Kerry LaPlante, PharmD, FCCP, FIDSA 
(@Kerry_LaPlante)

  • Restructure of the organization, with creation of a Teams and Director approach along with committee expansion to ensure success of the strategic plan 
  • Creating a new vision and mission for SIDPs future
  • Ensuring a pharmacist is on every therapeutic guideline
  • Formalizing SIDP's partnership with IDWeek.  It took about 5 years - started with Jason Gallagher and I served at the time the deal was closed

2018–2019

Jason Pogue, PharmD, BCPS, BCIDP  
(@jpogue1)

  • COVID-19 Pandemic
  • SIDP members showed dedication, commitment, and expertise to the global community to help ensure that [patients were optimally managed, and that the public was informed as it related to the latest on the prevention and treatment of this devastating disease.
  • SIDP members created and constantly updated educational content for the management of COVID-19
  • Members were stretched incredibly thin by increasing demands in their day to day practice, but still willingly put in extra time and effort to give back to the Society



Society of Infectious Diseases Pharmacists •  110 E. Schiller St., Suite 230, Elmhurst, IL 60126
(331) 248-7888sidp@affinity-strategies.com
Proudly Managed by Affinity Strategies

Powered by Wild Apricot Membership Software